StockData

INVO Fertility vs WORK Medical Technology

IVF and WOK side by side, both in surgical, medical, and dental instruments and supplies. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How IVF and WOK compare

WORK Medical Technology keeps more of each dollar of sales as profit, with a net margin of −10.9% compared with −92.3% at INVO Fertility.

WORK Medical Technology scores higher on the StockData Score (5 against 4 for INVO Fertility), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricIVFWOK
Size and price
Market cap$6.5M–
Share price$2.60$1.20
Change, 1 year−97.1%−100.0%
Change, 5 years−100.0%–
Beta (5Y)1.641.16
Employees1446
StockData Score
Total score45 (better)
Valuation score1 (better)0
Growth score1 (better)0
Performance score12 (better)
Health score13 (better)
Dividend score00
Valuation
P/S0.9×–
P/B0.4×–
Growth
Revenue growth (TTM)–−14.4%
Revenue growth, 5Y average45.8%–
Profitability
Gross margin–23.8%
Operating margin−78.7%–
Net margin−92.3%−10.9% (better)
FCF margin–49.9%
Return on equity−149%−5.0% (better)
Return on invested capital−81.4%–
Financial health
Debt / equity0.10 (better)0.22
Net debt / EBITDA–9.70
Interest coverage−5.2×–
Current ratio0.711.37 (better)
Altman Z-score−5.34–
Piotroski F-score25 (better)
Dividends and buybacks
Shareholder yield0.00%–
Ownership
Held by institutions5.2%0.00%
Held by insiders5.2%0.22%
Insider net buying, 12 months−$6 (better)−$178K
Short interest, % of float0.32%0.13%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.